Friedreich’s ataxia is a genetic disorder that causes progressive damage to the nervous system and brain, leading to a loss ...

Goldfeld received her award at the 2025 NFID Awards Gala and Silent Auction in October in Washington, DC. Jie Yang, HMS ...

It’s about co-creating science.” The event highlighted pathogen research discoveries and pandemic prevention efforts from ...

Gordon Freeman, Harvard Medical School professor of medicine at Dana-Farber Cancer Institute, and Arlene Sharpe, the ...

“Over the past 55 years, HST has proven that when engineers, scientists, and clinicians get together, human health leaps ...

A new AI model called popEVE can predict how likely each variant in a patient’s genome is to cause disease. The team is testing popEVE in clinical settings to see if it can speed accurate diagnoses of ...

Luca Maini, assistant professor of health care policy in the Blavatnik Institute at Harvard Medical School, studies competition and regulation in pharmaceutical markets. He has studied how national ...

Researchers have developed an AI system called Dr. CaBot that spells out its reasoning as it works through challenging medical cases and reaches a diagnosis. For the first time, the New England ...

A protein called STUB1 weakens the cancer-killing power of immune T cells by blocking key signals they need to attack tumors. Disabling STUB1 in lab experiments strengthened T cells’ response to the ...

Top row: In a mouse model of Alzheimer's disease, lithium deficiency (right) dramatically increased amyloid beta deposits in the brain compared with mice that had normal physiological levels of ...

Three key players share the story of how fundamental discoveries in the laboratory became a first-of-its-kind therapy that promises to have a monumental impact on sickle cell disease patients around ...

Love has been the source of ceaseless fascination since antiquity. Artists have tried to capture its beauty and darkness in books, paintings, and songs. Behavioral scientists have explored love as a ...